Seizure freedom reduces illness intrusiveness and improves quality of life in epilepsy

Canadian Journal of Neurological Sciences

Volumn 35, Issue 3, 2008, Pages 280-286

  Poochikian Sarkissian, Sonia ^a,b   Sidani, Souraya ^b   Wennberg, Richard ^a   Devins, Gerald M ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; AFFECT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EMOTIONAL STRESS; EPILEPSY; FEMALE; HAPPINESS; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RATING SCALE; RISK BENEFIT ANALYSIS; SEIZURE; SELF ESTEEM; UNSPECIFIED SIDE EFFECT;

EID: 51349102148     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100008842     Document Type: Article

References (55)

1. Dodrill CB, Batzel LW, Queisser HR, Temkin NR. An objective method for the assessment of psychological and social problems among epileptics. Epilepsia. 1980; 21: 123-35.
2. Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a UK community study. Epilepsia. 1996; 37: 148-61.
3. Hermann BP, Whitman S, Wyler AR, Antin MT, Vanderzwagg R. Psychological predictors of psychopathology in epilepsy. Br J Psychiatry. 1990; 156: 98-105.
4. Baker GA, Jacoby A, Chadwick DW. The associations of psychopathology in epilepsy: a community study. Epilepsy Res. 1996; 25: 29-39.
5. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology. 2002; 58 Suppl 5: S9-19.
6. Vickrey BG, Hays RD, Engel J Jr, Spritzer K, Rogers WH, Rausch R, et al. Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life. Ann Neurol. 1993; 37: 158-66.
7. Vickrey BG, Hays RD, Rausch R, Engel J Jr, Visscher BR, Ary CM, et al. Outcomes in 248 patients who had diagnostic evaluations for epilepsy surgery. Lancet. 1995; 346: 1445-9.
8. Wiebe S, Blume W, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. New Eng J Med. 2001; 345: 311-18.
9. Leidy NK, Elixhauser A, Vickrey B, Means E, Willian MK. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology. 1999; 53: 162-6.
10. Chadwick D. Better comparisons of antiepileptic drugs: what measures of efficacy? Pharm World Sci. 1997; 19: 214-6.
11. Birbeck GL, Hays RD, Cui X, Vickrey B. Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia. 2002; 43: 535-8.
12. Engel J Jr, Van Ness PC, Rasmussen TB, Ojemann LM. Outcome with respect to epileptic seizures. In: Engel J Jr, editor. Surgical treatment of epilepsies. New York: Raven Press; 1993. p. 609-21.
13. Spencer DD, Inserni J. Temporal lobectomy. In: Luders HO, editor. Epilepsy surgery. New York: Raven Press; 1991. p. 533-45.
14. Taylor DC, Falconer MA. Clinical, socioeconomic, and psychological changes after temporal lobectomy for epilepsy. Br J Psychiatry. 1968; 114: 1247-61.
15. McLachlan RS. The Canadian epilepsy database and registry. Can J Neurol Sci. 1998; 25 Suppl 4: S27-31.
16. Dodrill CB, Batzel LW, Fraser R. Psychosocial changes after surgery for epilepsy. In: Luders HO, editor. Epilepsy surgery. New York: Raven Press; 1991. p. 661-7.
17. Guldvog B, Loyning Y, Hauglie-Hassen E, Flood S, Bjornaes H. Surgical versus medical treatment for epilepsy. Outcome related to survival, seizures, and neurologic deficit. Epilepsia. 1991; 32: 375-88.
18. Rose KJ, Derry PA, McLachlan RS. Patient expectations and postoperative depression, anxiety and psychosocial adjustment after temporal lobectomy: a prospective study. Int J Behav Med. 1997; 2: 27-40.
19. Wass CT, Rajala MM, Hughes JM, Sharbrough FW, Offord MS, Rademacher DM, et al. Long-term follow-up of patients treated surgically for medically intractable epilepsy: results in 291 patients treated at Mayo Clinic Rochester between July 1972 and March 1985. Mayo Clinic Proc. 1996; 71: 1105-13.
20. Bishop M, Allen C. The impact of epilepsy on quality of life: a qualitative analysis. Epilepsy Behav. 2003; 4: 226-33.
21. Devins GM, Binik YM, Hutchinson TA, Hollomby DJ, Barre PE, Guttmann RD. The emotional impact of end-stage renal disease: importance of patients' perceptions of intrusiveness and control. Int J Psychiatry Med. 1983; 13: 327-43.
22. Devins GM. Illness intrusiveness and the psychosocial impact of lifestyle disruptions in chronic life-threatening disease. Adv Renal Replace Ther. 1994; 1: 251-63.
23. Devins GM, Edworthy SM, Seland TP, Klein GM, Paul LC, Mandin H. Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Nerv Ment Dis. 1993; 181: 377-81.
24. Devins GM, Edworthy SM, Guthrie NG, Martin L. Illness intrusiveness in rheumatoid arthritis: differential impact on depressive symptoms over the adult lifespan. J Rheumatol. 1992; 19: 709-15.
25. Devins GM, Edworthy SM. Illness intrusiveness explains race-related quality-of-life differences among women with systemic lupus eythematosus. Lupus. 2000; 9: 534-41.
26. Devins GM, Armstrong SJ, Mandin H, Paul LC, Hons RB, Burgess ED, et al. Recurrent pain, illness intrusiveness and quality of life in end-stage renal disease. Pain. 1990; 42: 279-85.
27. Devins GM, Beanlands H, Mandin H, Paul LC. Psychosocial impact of illness intrusiveness moderated by self-concept and age in end-stage renal disease. Health Psychol. 1997; 16: 529-38.
28. Bloom JR, Stewart SL, Johnston M, Banks P. Intrusiveness of illness and quality of life in young women with breast cancer. Psychooncology. 1998; 7: 89-100.
29. Antony MM, Roth D, Swinson RP, Huta V, Devins GM. Illness intrusiveness in individuals with panic disorder, obsessive compulsive disorder or social phobia. J Nerv Ment Dis. 1998; 186: 311-5.
30. Robb JC, Cooke RG, Devins GM, Young LT, Joffe RT. Quality of life and lifestyle disruption in euthymic bipolar disorder. J Psychiatr Res. 1997; 31: 509-17.
31. Binik YM, Devins GM. Transplant failure does not compromise quality of life in end-stage renal disease. Int J Psychiatry Med. 1986; 16: 281-92.
32. Littlefield C, Abbey S, Fiducia D, Cardella C, Greig P, Levy G, et al. Quality of life following transplantation of the heart, liver, and lungs. Gen Hosp Psychiatry. 1996; 18 Suppl 6: S36-47.
33. Devins GM, Flanagan M, Morehouse R, Moscovitch A, Plamondon J, Reinish L, et al. Differential illness intrusiveness associated with sleep-promoting medications. Eur Psychiatry. 1995; 10 Suppl: S153-9.
34. Poochikian-Sarkissian S. Illness intrusiveness, quality of life and self-concept in epilepsy. Ph.D. Thesis, Toronto (ON): University of Toronto; 2005.
35. Gilliam F, Kuzniecky R, Meador K. Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology. 1999; 53: 687-94.
36. Lehrner J, Kalchmay R, Serles W. Health-related quality of life, activity of daily living and depressive mood disorder intemporal lobe epilepsy patients. Seizure. 1999; 8: 88-92.
37. SPSS 7.0 Statistical algorithms [Computer Program Manual]. Chicago, (IL); 1996.
38. Cohen J, Cohen P. Applied multiple regression/correlation analysis for the behavioral sciences, 3rd ed. Mahwah: Lawrence Erlbaum Associates; 2003.
39. Flanagan JC. A research approach to improving our quality of life. Am J Psychol. 1978; 33: 138-47.
40. McDowell J, Newell C. Measuring health: a guide to rating scales and questionnaires. Oxford University Press: New York; 1996.
41. Bradburn NM. The structure of psychological well-being, 1st ed. Aldine: Chicago; 1969.
42. Atkinson TA. The stability and validity of quality of life measures. Soc Indic Res. 1982; 10: 113-32.
43. Rosenberg M. Conceiving the self. New York: Basic Books; 1979.
44. Robinson JP, Shaver PR, Wrightsman LS. Measures of personality and psychological attitudes. San Diego: Academic Press; 1991.
45. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Measures. 1977; 3: 385-401.
46. Cramer JA, Perrine K, Devinsky O, Meador K. A brief questionnaire screen for quality of life in epilepsy: the QOLIE-10. Epilepsia. 1998; 37: 577-87.
47. Devinsky O, Vickrey BG, Cramer J, Parrine K, Hermann B, Meador K, et al. Development of the quality of life in epilepsy inventory. Epilepsia. 1995; 36: 1089-104.
48. Dodrill CB, Breyer DN, Diamond MB, Dubinsky BL, Geary BB. Psychosocial problems among adults with epilepsy. Epilepsia. 1984; 25: 168-75.
49. Hermann BP, Whitman S. Behavioural and personality correlates of epilepsy: a review, methodological critique, and conceptual model. Psychol Bull. 1984; 95: 451-97.
50. Edworthy SM, Dobkin PL, Clarke AE, Da Costa D, Dritsa M, Fortin PR, et al. Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosus. J Rheumatol. 2003; 30: 1011-6.
51. Devins GM, Mendelssohn DC, Barre PE, Binik YM. Predialysis psychoeducational intervention and coping styles influence time to dialysis in chronic kidney disease. Am J Kidney Dis. 2003; 42: 693-703.
52. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002; 288: 2469-75.
53. Ware JEJ, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) Conceptual framework and item selection. Med Care. 1992; 30: 473-83.
54. Kanner AM, Balabanov A. Depression in epilepsy: how closely related are these two disorders? Neurology. 2002; 58 Suppl 5: S27-39.
55. Brodie MJ, Leach JP. Success or failure with antiepileptic drug therapy: beyond empiricism? Neurology. 2003; 60: 162-3.